39
Views
9
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Allergic reaction to chlorambucil in chronic lymphocytic leukemia presenting with fever and lymphadenopathy

&
Pages 1195-1197 | Received 05 Feb 2005, Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Valentin Goede, Barbara Eichhorst, Kirsten Fischer, Clemens-Martin Wendtner & Michael Hallek. (2015) Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia. Leukemia & Lymphoma 56:6, pages 1585-1592.
Read now

Articles from other publishers (8)

Rawan Abdullah, Irina Badralexi & Andrei Halanay. (2023) Stability Analysis in a New Model for Desensitization of Allergic Reactions Induced by Chemotherapy of Chronic Lymphocytic Leukemia. Mathematics 11:14, pages 3225.
Crossref
Whitney A. High. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy 209 221.e5 .
John C. Byrd & Joseph M. Flynn. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1958 1978.e7 .
Elisabeth Livingstone, Lisa Zimmer, Larissa Leister & Dirk Schadendorf. 2013. Dermatologic Principles and Practice in Oncology. Dermatologic Principles and Practice in Oncology 145 159 .
Whitney A. High. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy 212 227.e4 .
Nadia Ben Fredj, Karim Aouam, Amel Chaabane, Leila Njim & Naceur Boughattas. (2013) Delayed Cross‐Reactivity Between Cyclophosphamide and Chlorambucil. The Journal of Clinical Pharmacology 52:5, pages 771-774.
Crossref
Ekaterini Syrigou, Nektaria Makrilia, Ioanna Koti, Muhammad W. Saif & Kostas N. Syrigos. (2009) Hypersensitivity reactions to antineoplastic agents: an overview. Anti-Cancer Drugs 20:1, pages 1-6.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.